Ctr. for Biological Diversity v. National Biomedical Research
This text of Ctr. for Biological Diversity v. National Biomedical Research (Ctr. for Biological Diversity v. National Biomedical Research) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 23 2020 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT
CENTER FOR BIOLOGICAL No. 18-15997 DIVERSITY, D.C. No. 4:16-cv-00527-BGM Plaintiff-Appellee,
v. MEMORANDUM*
UNITED STATES FISH AND WILDLIFE SERVICE,
Defendant,
and
NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH,
Intervenor-Defendant- Appellant.
Appeal from the United States District Court for the District of Arizona Bruce G. Macdonald, Magistrate Judge, Presiding
Submitted April 16, 2020** San Francisco, California
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). Before: HAWKINS and PAEZ, Circuit Judges, and RESTANI,*** Judge.
Intervenor-Defendant-Appellant National Association for Biomedical
Research (NABR) appeals the district court’s entry of judgment in favor of
Plaintiff-Appellee Center for Biological Diversity (CBD) and against Defendant
United States Fish and Wildlife Service (Service). After judgment was entered,
NABR intervened to protect the confidentiality of its member-companies’
information regarding the importation and exportation of wildlife. The sole issue
on appeal is whether this information should be shielded from disclosure under
“Exemption 4” of the Freedom of Information Act (FOIA), which protects
“commercial or financial information obtained from a person and . . . confidential.”
5 U.S.C. § 552(b)(4). The district court, relying on the then-applicable definition
of “confidential,” determined that the disclosure of this information was not likely
to cause substantial competitive harm and so granted summary judgment to CBD
and ordered the Service to disclose the information.1
While this appeal was pending, the Supreme Court decided Food Marketing
Institute v. Argus Leader Media, 139 S. Ct. 2356 (2019), which addressed
Exemption 4. The Court rejected our definition of “confidential” and adopted a
*** The Honorable Jane A. Restani, Judge for the United States Court of International Trade, sitting by designation. 1 Although the district court partially granted the Service summary judgment, CBD’s other claims are not at issue in this appeal.
2 new definition. Id. at 2362–66. Specifically, the Court held that Exemption 4 is
triggered at least where the commercial information “is both [1] customarily and
actually treated as private by its owner and [2] provided to the government under
an assurance of privacy.” Id. at 2366. Although it is sufficient to show both
prongs, the Court declined to address whether the second prong is necessary. Id. at
2363.2 We agree with the parties that Food Marketing alters the governing
standard for evaluating whether Exemption 4 bars disclosure. See Lambert v.
Blodgett, 393 F.3d 943, 973 n.21 (9th Cir. 2004).
We vacate the judgment as it applies to NABR and remand for further
proceedings. The district court did not have the benefit of Food Marketing in
deciding whether the disputed information is “confidential,” and we decline to
apply the new legal standard in the first instance. See Clark v. Chappell, 936 F.3d
944, 971–72 (9th Cir. 2019) (remanding where “we are without the benefit of the
district court’s analysis on the new standard” (internal quotation marks and citation
omitted)). Similarly, because the district court assumed without deciding that the
information was “commercial information,” we decline to resolve that issue. See
Shirk v. U.S. ex rel. Dep’t of Interior, 773 F.3d 999, 1007 (9th Cir. 2014) (“As a
2 Although GSA v. Benson remarked that requiring government assurance of privacy “seem[ed] correct,” its holding rested on what would later become Food Marketing’s first prong. 415 F.2d 878, 881–82 (9th Cir. 1969). Thus, Benson does not resolve the open question as to Food Marketing’s second prong.
3 federal court of appeals, we must always be mindful that we are a court of review,
not first view.” (internal quotation marks and citation omitted)).
Remand is particularly appropriate here because the factual record may
benefit from further development as to both of Food Marketing’s prongs. As to the
first prong, NABR members’ declarations imply that they “customarily and
actually” treat the commercial information as private, though they did not say how.
Likewise, the declarations do not address whether the companies designated the
information as “confidential” when they submitted the information to the Service,
which may also be relevant. As to the second prong, CBD here asks that we take
judicial notice of a document that may be relevant to whether the information at
issue in this case was “provided to the government under an assurance of privacy”
but that CBD inadvertently failed to file with the district court. On remand the
district court may, if necessary, determine how to consider the significance of this
evidence in the first instance. See Clark, 936 F.3d at 972 (remanding where
appellant submitted new evidence for the first time on appeal).3 As to both prongs,
the district court has a “variety of tools” to more fully develop the record, if
necessary. Betz v. Trainer Wortham & Co., 610 F.3d 1169, 1171 (9th Cir. 2010).
For the above reasons we vacate the order granting summary judgment to
CBD and against the Service. The district court in its discretion may allow the
3 We accordingly deny CBD’s request for judicial notice as moot.
4 parties to supplement the factual record in light of the new standard adopted in
Food Marketing.
VACATED in part and REMANDED for further proceedings. The parties
shall bear their own costs on appeal.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Ctr. for Biological Diversity v. National Biomedical Research, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ctr-for-biological-diversity-v-national-biomedical-research-ca9-2020.